Nothing Special   »   [go: up one dir, main page]

Baker et al., 1976 - Google Patents

Immunochemical characterization of the" native" type III polysaccharide of group B Streptococcus.

Baker et al., 1976

View PDF
Document ID
10279354076620695739
Author
Baker C
Kasper D
Davis C
Publication year
Publication venue
The Journal of experimental medicine

External Links

Snippet

The type III polysaccharide of-roup B Streptococcus has been isolated and purified by a method that employs washing of intact cells at neutral pH. That the polysaccharide prepared by this procedure is the" native" type III antigen is suggested by its molecular size in excess …
Continue reading at europepmc.org (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)

Similar Documents

Publication Publication Date Title
Baker et al. Immunochemical characterization of the" native" type III polysaccharide of group B Streptococcus.
Boyd et al. Fractionation of hemagglutinating and bacterial binding adhesins of Bacteroides gingivalis
Fournier et al. Purification and characterization of Staphylococcus aureus type 8 capsular polysaccharide
Baker et al. Quantitative determination of antibody to capsular polysaccharide in infection with type III strains of group B Streptococcus.
Kasper et al. Immunodeterminant specificity of human immunity to type III group B streptococcus.
Kasper The polysaccharide capsule of Bacteroides fragilis subspecies fragilis: immunochemical and morphologic definition
Lancefield et al. Type-specific polysaccharide antigens of group B streptococci
Beachey et al. Human immune response to immunization with a structurally defined polypeptide fragment of streptococcal M protein.
Fox M proteins of group A streptococci
Flesher et al. Characterization of lipopolysaccharide of Haemophilus influenzae
Glode et al. Cross-antigenicity and immunogenicity between capsular polysaccharides of group C Neisseria meningitidis and of Escherichia coli K92
Fournier et al. Isolation of type 5 capsular polysaccharide from Staphylococcus aureus
Pedersen et al. Purification, characterization, and immunological cross-reactivity of alginates produced by mucoid Pseudomonas aeruginosa from patients with cystic fibrosis
Apicella Antigenically Distinct Populations of Neisseria gonorrhoeaei Isolation and Characterization of the Responsible Determinants
Oeding Antigenic properties of Staphylococcus aureus
Mukasa et al. Structure and immunological specificity of the Streptococcus mutans group b cell wall antigen
Baker et al. Immunological investigation of infants with septicemia or meningitis due to group B Streptococcus
Narikawa et al. Streptococcus oralis previously identified as uncommon ‘Streptococcus sanguis’ in Behcet's disease
Edwards et al. Rapid diagnosis of type III group B streptococcal meningitis by latex particle agglutination
Kaijser Immunological Studies of an Antigen Common to many Gram-Negative Bacteria with Special Reference to E. coli: Characterization and Biological Significance
Baker et al. Identification of sialic acid in polysaccharide antigens in group B Streptococcus
Pier et al. High-molecular-weight polysaccharide antigen from Pseudomonas aeruginosa immunotype 2
Hamada et al. Chemical and immunological properties of the type f polysaccharide antigen of Streptococcus mutans
Challacombe et al. Natural antibodies in man to Streptococcus mutans: specificity and quantification.
Bokkenheuser Vibrio fetus infection in man: a serological test